RNF144B

Across TCGA pan-cancer cohorts, RNF144B Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated RNF144B data layer compared with 22 for mass-spec protein.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher RNF144B Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNF144B expression acts as an unfavorable survival marker.

LIHC, ACC, and READ are the cancer types where RNF144B Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Median	All	0.044	0.553	<.001	15	view →
ACC	DFS	Median	All	0.066	0.667	.002	12	view →
READ	DFS	Median	All	0.112	0.845	.001	12	view →
LUAD	DFS	Median	All	0.077	0.768	<.001	9	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RNF144B–LIHC (DFS)

Open the LIHC breakdown →